SIGMA Healthcare announced its annual financial results this morning with total net revenue of $3.3bn, down 9.2% from last year, largely reflecting the sale of its hospital distribution business in Mar last year, and elevated sales of RATs in FY2023 not repeated.
Sigma CEO and Managing Director Vikesh Ramsundar commented that today's results show "the strategy implemented over the past two years is now producing the outcomes that will help improve shareholder value".
"With our operating performance strong, we have been able to drive efficiencies, reducing total operating costs by 10.7% after absorbing CW merger proposal costs, providing a catalyst for our financial performance."
He said the divestment of non-core assets has delivered a leaner operating model.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Mar 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Mar 24
